USPTO serial 79405248
FIDIA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 7, 2026
- Examiner
- STRUCK, ROBERT J
- Law office
- FILE REPOSITORY (FRANCONIA)
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with FIDIA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Andrew N. Fredbeck
Andrew N. Fredbeck Fross Zelnick Lehrman & Zissu, P.C.151 West 42nd St., 17th Fl.New York, NY 10036United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry; chemicals for use in science; biological preparations for use in industry and science; plant extracts, other than essential oils, for use in the manufacture of pharmaceutical products and cosmetics; preservatives for use in the pharmaceutical industry; emollients for industrial purposes; antioxidants for use in the manufacture of pharmaceutical products, cosmetics and nutritional supplements; proteins for use in the manufacture of pharmaceutical products, cosmetics and nutritional supplements; vitamins for use in the manufacture of pharmaceutical products, cosmetics and nutritional supplements; active chemical ingredients for the production of pharmaceuticals for the treatment of joints, for the prevention and treatment of traumatic and degenerative joint pathologies, for the treatment of cancer, arthrosis, osteoarthritis and diseases of the muscular and skeletal system; active chemical ingredients for the production of pharmaceuticals for use in aesthetic and regenerative care; active chemical ingredients for the production of dermatological preparations, ophthalmological preparations, anti-inflammatory preparations, neurological preparations, cardiovascular preparations and gynecological preparations; chemical and biological preparations for the manufacture of pharmaceutical products, cosmetics, medicines, dietetic substances, nutritional supplements and health care products | ACTIVE | — |
| 003 | Non-medicated cosmetics and toiletry preparations; non-medicated dentifrices; essential oils; non-medicated soaps and bath gels, vaginal washes for personal sanitary or deodorant purposes; non-medicated vaginal douching preparations; shampoos; cosmetic preparations and lotions for hair care and beauty care; topical skin sprays for cosmetic use; dermocosmetic products not for medical use, namely, cosmetic preparations for skin care; creams, ointments, balms, lotions, oils and tanning sprays, with sunscreen and after-sun protection, namely, sunscreen preparations and after-sun lotions and creams; mouthwashes, not for medical purposes; oral hygiene preparations, namely, non-medicated mouth wash and rinse; eye-washes, not for medical purposes; moist wipes for sanitary and cosmetic purposes, namely, pre-moistened cosmetic wipes; eyeglass wipes impregnated with a detergent; baby wipes impregnated with cleaning preparations | ACTIVE | — |
| 005 | Pharmaceutical and medical preparations for the treatment of joints, for the prevention and treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgery; pharmaceutical and medical preparations for the treatment of arthrosis and osteoarthritis; pharmaceutical and medical preparations for the treatment of rheumatologic diseases; pharmaceutical and medical preparations for the treatment of diseases of the muscular and skeletal system; pharmaceutical and medical preparations for the prevention and treatment of allergic and autoimmune diseases, skin diseases, cancer and as an accompanying medication in cancer and pain therapy; dermatological preparations; rheumatological pharmaceutical preparations; ophthalmological preparations; anti-inflammatory preparations; analgesic preparations; gynecological pharmaceutical preparations; analgesic preparations; neurological pharmaceutical preparations, cardiovascular pharmaceutical preparations; anticoagulants; pharmaceutical preparations for use in aesthetic and regenerative care; veterinary preparations for equine use to treat conditions of the joints and inflammation; sanitary preparations for medical purposes; dietetic food and beverages adapted for medical and veterinary use; dietary supplements for human beings and animals; medical plasters, wadding for dressings; disinfectants; biological preparations for medical purposes, namely, human allograft tissue matrixes derived from amniotic membranes, human allograft tissue, biological tissue grafts, biological amniotic membrane tissue intended for injection for subsequent implantation; nutritional supplements with a cosmetic effect; nutritional supplements for human beings; nutritional supplements for animals; adhesive plasters for medical purposes; transdermal patches for the transdermal administration of pharmaceuticals for use in the treatment of dermatological diseases; gauze for dressings; eye drops; medicated eyewash; solutions for contact lenses; solutions for contact lens rinsing, sterilization, disinfection, neutralization; pre-filled syringes for medical purposes sold filled with pharmaceutical preparations for the treatment of joints, for the prevention and treatment of traumatic and degenerative joint pathologies and for use during orthopedic surgery, for treatment of arthrosis and osteoarthritis, for the treatment of rheumatologic diseases and for the treatment of diseases of the muscular and skeletal system; surgical implants comprised of living tissues | ACTIVE | — |
| 010 | Surgical instruments and apparatus; medical devices for the treatment of wounds, burns, ulcers, damaged skin and tissue, joint and musculo-skeletal diseases and disorders; Medical apparatus for the preparation and injection of Platelet-Rich Plasma (PRP); Blood processing kits comprised of apparatus for blood collection, separation of blood components, processing of blood and administration of blood for medical purposes being medical needles, medical syringes, sample preparation tubes and vials, holders for sample tubes and vials, and blood filters for medical purposes; syringes for medical purposes and cannulae; needles for medical purposes; devices for the injection of pharmaceutical preparations and medicines; medical-surgical devices for the treatment of joints, joint pathologies, traumatic and degenerative pathologies of the musculo-sketetal system and for use during orthopaedic surgery; surgical implants comprised of artificial materials; implantable subcutaneous drug delivery devices, namely, implantable drug delivery pumps | ACTIVE | — |
| 041 | Education, namely, conducting classes, seminars and workshops in the field of healthcare, aesthetic care, cosmetics, regenerative medicine and pharmaceuticals; arranging and conducting of workshops in the field of healthcare, aesthetic care and pharmaceuticals; arranging and conducting of conventions, conferences, seminars in the area of healthcare, aesthetic care and pharmaceuticals; organization of exhibitions for cultural or educational purposes; organization of sports competitions; publishing books, magazines and electronic publications; publication of texts, other than publicity texts; publication of the results of clinical trials for pharmaceutical and medical preparations | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Fidia Farmaceutici S.p.A.
- Other trademarks owned by Fidia Farmaceutici S.p.A.
- Other trademarks owned by Fidia Farmaceutici S.p.A.
- Other trademarks in Class 001
- Other trademarks in Class 003
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 041
- Similar marks named FIDIA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 1, 2026 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 12, 2026 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 12, 2026 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 7, 2026 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Apr 7, 2026 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 7, 2026 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Mar 12, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 25, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 25, 2026 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 17, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 17, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Feb 11, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 23, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 16, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jan 16, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 16, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 17, 2025 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2025 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 17, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 9, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 9, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Dec 29, 2024 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 10, 2024 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 10, 2024 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 26, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 3, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Oct 3, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 27, 2024 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 26, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |